Several commonly prescribed medications used for completely different illnesses can enhance or reduce the activity of the influenza virus.
NTNU researchers are on track to find drug combinations that could help stop the coronavirus across the globe.
A new study shows that people who have had concussions sometimes develop long-term after effects, including sleep disturbances. The findings could also be of use to other patient groups.
Certain type of cancer drugs that promote the death of cells can actually be harmful if combined with other treatments that damage our DNA, RNA or proteins, researchers have found.
Cancer researcher Marit Otterlei made a chance discovery of a brand new antibiotic that has proven effective after several experiments.
An analysis of 5 000 proteins from a blood sample is providing valuable information on a variety of diseases we might get or be at risk for. “Sensational” is the word from Christian Jonasson at the HUNT Research Centre about the US-British-Norwegian study.
“I am a doctor who reveals idiots as a hobby,” says Ben Goldacre. If so, it’s become a pretty comprehensive hobby.
Some medical research data never get published because they don’t fit in with the pharmaceutical industry’s desired results. Profiled researcher and social commentator Ben Goldacre will shed some light on this very topic when he takes part in NTNU’s The Big Challenge science festival in Trondheim in June.
The discharge of pharmaceutical drugs is a major problem around the world, but a new study of the freshwater fish burbot shows that there is hope.
The higher a person’s BMI, the greater the chance of getting psoriasis. But researchers are still uncertain as to why.
Metformin significantly reduces the risk of late miscarriages and preterm births for women with PCOS. But the drug does not work to prevent gestational diabetes, according to a large Nordic study from NTNU and St. Olavs hospital.
Some pregnant women are so conflicted about abortion that they don’t even talk about it with their own mother.
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
Back in the 1970s, a Norwegian family was found to have abnormally high red blood cell counts. Thirty-five years later, researchers succeeded in solving the mystery, thanks to new analytical methods and the latest developments in genetic engineering – and a chance meeting with a Swiss scientist.
Only a small percentage of medical students become full-time researchers. But university research tracks have increased the proportion of doctoral degrees taken tenfold.
No, this question isn’t only for people who’ve smoked a lot. Seven factors, including two new ones, can predict whether you have a high risk of developing lung cancer.
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming. Testing existing anti-viral drugs for their ability to combat multiple viral infections can help.
Every day people are whisked into Norwegian hospital emergency rooms with concussions. A new study shows that even mild head trauma can cause major problems in daily life.
A treatment that kills the cancer cells in one fell swoop, without causing the patient to feel sick from the medication’s side effects? That’s the goal of new personalized cancer therapies that are being developed across the globe, including at NTNU.
Organizational downsizing and job loss greatly increase a person’s risk of having to start different medications. Prescriptions for drugs to treat mental health issues are particularly widespread in this group.
A new approach to cancer treatment combines ultrasound, bubbles and nanoparticles with chemotherapy. In an experiment, the treatment has cured cancer in mice.